Maria Sharapova was found guilty of taking a performance enhancing drug. She announced on Monday that she failed her drug test that she took back in January. She has taken the drug Mildronate, also known as Meldonium, for 10 years to address a number of health issues including an irregular heart beat. The punishment hasn’t been officially decided but the suspension can be anywhere between 1-4 years. Her 35 singles titles and 5 Grand Slam titles—2 at the French Open and 1 each at the Australian Open, Wimbledon, and US Open—rank 3rd among active players, behind Serena and Venus Williams.
Personally, I’ve never really liked Sharapova as a person, but I do respect her talent. I hope to see her back on the court within a year because this time it seemed like an honest mistake. Sharapova agrees with me. Yesterday at a press conference she said, “I know with this that I face consequences,” Sharapova said. “I don’t want to end my career this way, and I really hope I’m given another chance to play this game.”
We’ll see if she gets her sponsors back because this mistake cost her a $100 million sponsorship deal with Nike.